Abstract: The present invention generally relates to methods and compositions for treating pathogenic vaginal biofilms. More specifically, the invention relates to pharmaceutical compositions comprising a combination of boric acid and diethylaminetetracetic acid (EDTA) and to methods of using such compositions to treat or prevent biofilm formation associated with vaginal infections, such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), trichomoniasis or mixed infections.

Abstract: The present invention generally relates to methods and compositions for treating pathogenic vaginal biofilms. More specifically, the invention relates to pharmaceutical compositions comprising a combination of boric acid and diethylaminetetracetic acid (EDTA) and to methods of using such compositions to treat or prevent biofilm formation associated with vaginal infections, such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), trichomoniasis or mixed infections.

Abstract: The present invention generally relates to methods and compositions for treating pathogenic vaginal biofilms. More specifically, the invention relates to pharmaceutical compositions comprising a combination of boric acid and diethylaminetetracetic acid (EDTA) and to methods of using such compositions to treat or prevent biofilm formation associated with vaginal infections, such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), trichomoniasis or mixed infections.

Abstract: A pair of sheets defining a disposable sheath for covering the electrical leads in a monitoring system used for monitoring patient vital signs and secured together along edges and along spaced seams to define a plurality of longitudinally extending compartments. A plurality of tear lines extend along the spaced seams from the second end to a distance spaced from the first end for laterally separating the compartments into separate arms, and fingers, whereby electrical leads may be bundled together in the open distance at the first end and inserted into the arms and fingers. A seal seals the sheets about the electrical leads at the respective ends.

Abstract: The present invention generally relates to methods and compositions for treating pathogenic vaginal biofilms. More specifically, the invention relates to pharmaceutical compositions comprising a combination of boric acid and diethylaminetetracetic acid (EDTA) and to methods of using such compositions to treat or prevent biofilm formation associated with vaginal infections, such as bacterial vaginosis (BV), vulvovaginal candidiasis (VVC), trichomoniasis or mixed infections.

Abstract: A pair of sheets defining a disposable sheath for covering the electrical leads in a monitoring system used for monitoring patient vital signs and secured together along edges and along spaced seams to define a plurality of longitudinally extending compartments. A plurality of tear lines extend along the spaced seams from the second end to a distance spaced from the first end for laterally separating the compartments into separate arms, and fingers, whereby electrical leads may be bundled together in the open distance at the first end and inserted into the arms and fingers. A seal seals the sheets about the electrical leads at the respective ends.